Fibrokit
Fibromyalgia is a chronic condition that affects 6% of the global population. It is characterised by constant, widespread pain that is, in many cases, debilitating. This disease is not yet fully characterised at the molecular level, complicating its diagnosis and treatment.
To support healthcare professionals in both diagnosis and treatment, Fibrokit provides an innovative solution. This molecular test is based on the analysis of diagnostic biomarkers from blood and stool samples, enabling a more precise way to diagnose and address the disease.
Fibrokit Benefits
Accelerate fibromyalgia diagnosis
Identify specific health imbalances to personalise patient treatment
Predict the effectiveness of different ongoing therapies
Evaluate potential causes of pain, fatigue, and gastrointestinal discomfort
Establish key parameters for monitoring patient treatment and condition progression
Recommendations
Fibrokit is recommended for patients experiencing:
Widespread chronic pain
Recurrent joint stiffness
Constant fatigue and sleep disturbances
Gastrointestinal disorders
Cognitive difficulties or 'fibro fog'"
Chronic pelvic pain and dysmenorrhea
Family history of fibromyalgia
Test procedure

Sample collection
Two peripheral blood tubes (drawn by a healthcare professional) and two stool samples (collected at home by the patient) are required.

Preservation
Keep both tubes containing the blood sample at 4°C and the stool samples properly refrigerated until shipment.

Results
Results will be delivered within 20 business days from the arrival of the samples at the laboratory, along with a detailed report.
The Fibrokit test provides a more comfortable and fulfilling life for those affected by fibromyalgia.
Brochure with exclusive information for healthcare professionals
Folleto con información exclusiva para profesionales: